ANTONAZZO IPPAZIO COSIMO

Role
Assistant Professor  
Academic disciplines
Hygiene and Public Health (MEDS-24/B)
Scientific-Disciplinary Group:
MEDICAL STATISTICS, HYGIENE, PUBLIC HEALTH, NURSING AND MIDWIFERY (06/MEDS-24)

Publications

  • Losa, L., Antonazzo, I., Di Martino, G., Mazzaglia, G., Tafuri, S., Mantovani, L., et al. (2024). Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression. VACCINES, 12(5) [10.3390/vaccines12050527]. Detail

  • Antonazzo, I., Cortesi, P., Zanon, E., Pasca, S., Morfini, M., Santoro, C., et al. (2024). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. MEDICINA, 60(1) [10.3390/medicina60010034]. Detail

  • Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Detail

  • Ponticelli, D., Losa, L., Antonazzo, I., Zampella, A., Di Marino, F., Mottola, G., et al. (2024). Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy. INFECTIOUS DISEASE REPORTS, 16(1), 128-141 [10.3390/idr16010010]. Detail

  • Brauer, M., Roth, G., Aravkin, A., Zheng, P., Abate, K., Abate, Y., et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440 (18–24 May 2024)), 2162-2203 [10.1016/s0140-6736(24)00933-4]. Detail